Drug profile · INN
histrelin acetate
VANTAS
histrelin acetate (VANTAS) is a gonadotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — histrelin acetate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
histrelin acetate (VANTAS) is a gonadotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is histrelin acetate?
histrelin acetate (VANTAS) is a gonadotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for histrelin acetate?
VANTAS is a marketed brand name for histrelin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of histrelin acetate?
histrelin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.